Comedian Gabriel Iglesias shared his experience with Ozempic, revealing that he quit the medication after five months and quickly regained 20 lbs.

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound after stopping GLP-1 medications.

Research out today might provide even more of a reason for people to stay on GLP-1 medications like semaglutide, the active ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

Comedian Gabriel Iglesias could have earned $1 million, but his Ozempic revelation explains why he walked away.

CagriSema is has been positioned as a next-level GLP-1. Even if it doesn't dethrone the greats, doctors say it could still ...

News and commentary from the psychiatry world ...

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage ...

Ozempic has been a breakthrough for many, correcting eating disorders and managing blood sugar, weight, and more. A recent New Yorker article highlights an under-discussed bio-psychological side ...

The new racial body horror movie, Slanted, is asking hard questions about how we as a culture deal with social inequality.